CD14 and atherosclerosis: Similarly, in human patients there was a small, but statistically significant, CD14++CD16− inflammatory subset preponderance at 48 h (82.9 ± 6.9% vs. 75.9 ± 5.1% (P < 0.001), compared with control patients with stable atherosclerosis (Figure 1G).